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Abstract
Objective: To evaluate the association between mood and anxiety disorders in Hashimoto
disease and Euthyroid Goitre in a case control study.
Methods: Cases included 19 subjects with Hashimoto disease in euthyroid phase, 19 subjects with
euthyroid goitre, 2 control groups each of 76 subjects matched (4/1) according to age and sex
drawn from the data base of a community based sample. Psychiatric diagnoses were formulated
using the International Composite Diagnostic Interview Simplified, according to DSM-IV criteria.
All subjects underwent a complete thyroid evaluation including physical examination, thyroid
echography and measure of serum free T4 (FT4), free T3 (FT3), thyroid-stimulating hormone
(TSH) and anti-thyroid peroxidase autoantibodies (anti-TPO). Results: Subjects with Hashimoto
disease showed higher frequencies of lifetime Depressive Episode (OR = 6.6, C.L. 95% 1.2–25.7),
Generalized Anxiety Disorders (OR = 4,9 Cl 95% 1.5–25.4) and Social Phobia (OR = 20.0, CL 95%
2.3–153.3) whilst no differences were found between subjects with goitre and controls.
Conclusion: The study seems to confirm that risk for depressive disorders in subjects with
thyroiditis is independent of the thyroid function detected by routine tests and indicates that not
only mood but also anxiety disorders may be associated with Hashimoto disease.
Introduction
Clinical and epidemiological studies seem to indicate that
an association between high levels of thyroid autoanti-
bodies may be implicated in the increased frequencies of
mood disorders observed in thyroid disease, independ-
ently of impairment of thyroid function [1-3]. A study car-
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autoimmunity in the association between celiac disease
and panic disorder and major depressive disorder [4].
The aim of the present study was to compare 2 clinical
samples of subjects, one with Hashimoto disease (in
euthyroid phase) and the second with euthyroid goitre
versus controls drown from a community sample, in
order to clarify whether the association of mood and anx-
iety disorder in Hashimoto disease is evident prior to
impairment of thyroid dysfunction.
Methods
Design: case control study
Cases: 19 subjects, 18 females, mean age 39.7+/-12.6,
with Hashimoto disease in euthyroid phase and 19 sub-
jects, 16 females, mean age 38.1+/-10.4, with euthyroid
goitre, all of whom were attending the Endocrinological
Unit of the Department of Internal Medicine, University
of Cagliari, Italy.
Two control groups, each of 76 subjects aged 18–64 years,
were obtained by matching each "case" with four "con-
trols" randomly selected on the basis of demographic
characteristics (sex and age) from the data base of a larger
population enrolled during a previous epidemiological
study aimed at defining the prevalence of psychiatric [5]
and thyroid diseases [6] in Sardinia. Controls were
selected by a technique of randomisation after matching.
For each case, a cell was formed containing all possible sex
and age-matched controls (~1.0 year). The number of
cells varied from 5 to 12 controls; a control was extracted
at random from each cell. Exclusion criteria for control
groups were the presence of abnormal values of serum
free T4, free T3, thyroid-stimulating hormone (TSH) and
anti-thyroid peroxidase autoantibodies (anti-TPO) as will
be specified.
Two standardized forms were used to acquire information
concerning: demographic data, state of health and use of
social and health services. Psychiatric diagnosis was made
using the Italian Simplified version of the Composite
International Diagnostic Interview (CIDIS) [7]. The com-
puter elaboration of data obtained enabled prevalence of
psychiatric disorders according to DSM-IV [8] diagnostic
criteria to be calculated.
All subjects underwent a complete thyroid evaluation
including physical examination, thyroid echography and
measure of serum free T4 (FT4), free T3 (FT3), thyroid-
stimulating hormone (TSH) and anti-thyroid peroxidase
autoantibodies (anti-TPO). FT4 and FT3 were measured
by means of a chromatographic method based on separa-
tion of free T4 on Lisophase columns (Technogenetics,
Milan, Italy; normal values: FT4 6.6–16 pg/ml; FT3 2.8–
5.6 pg/ml); TSH was measured by a chemiluminescent
method (Ortho-Clinical Diagnostics Amersham, U.K.)
with normal values ranging from 0.3–3.0 µU/ml. Thyroid
echography was performed using a "real time" echograph
(ALOKA Mod SSD 500 with a small parts 7.5 Mhz sound.
Anti-TPO, considered as the most sensitive and specific
marker of thyroid autoimmunity [9] was determined by
RIA (Sorin Biomedica Diagnostics, Saluggia, Italy) with a
cut-off value of 20 IU/ml.
Results
Subjects with Hashimoto disease displayed high frequen-
cies of lifetime Depressive Episodes (OR = 6.6, C.L. 95%
1.2–25.7), Generalized Anxiety Disorders (OR = 4,9 Cl
95% 1.5–25.4), Social Phobia (OR = 20.0, CL 95% 2.3–
153.3) and Primary Sleep Disorders (OR = 20.0, CL 95%
2.3–153.3); a tendency towards an increased frequency of
Panic Disorder was observed, although statistical signifi-
cance was not reached (OR = 1.8, 0.1–24.6). No differ-
ences were found in the evaluation of lifetime prevalence
of DSM-IV Psychiatric Disorders between patients with
Euthyroid goitre and controls (Table 1).
Discussion
This study seems to indicate an association between the
presence of a lifetime diagnosis of mood or anxiety disor-
der and Hashimoto disease without functional thyroid
impairment. No difference was observed in mood and
anxiety disorders between goitre cases and controls.
These findings are congruent with the results of a previous
study [10] that indicated a risk for Depressive episode in
subjects with antiTPO+ in a general population sample
without selection by medical or psychiatric health facili-
ties, and are consistent with several previous clinical stud-
ies providing evidence of a significant association of
mood disorders or post-partum depression and symp-
tomless autoimmune thyroiditis with or without sub-clin-
ical hypothyroidism [11].
The above-cited community survey found that subjects
with at least one lifetime diagnosis of anxiety disorders
presented anti-TPO+ more frequently than subjects with-
out mood or anxiety disorders. However, no specific anx-
iety diagnosis was found to be associated with anti-TPO+,
although General Anxiety Disorder showed a strong trend
toward association (P < 0.058). Anxiety Disorder Not
Otherwise Specified was more frequently observed with
anti-TPO+, but this is only a sub-threshold condition. A
previous research carried out on celiac patients indicated
thyroid autoimmunity as possible risk factor for panic dis-
order [3]. In the present study, the latter diagnosis was
shown to be more frequent between Hashimoto disease
and controls, although statistical significance was not
reached.Page 2 of 4
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of possible risk for anxiety disorders such Generalized
Anxiety Disorder, Social Phobia and Panic Disorder in
Hashimoto Disease.
To our knowledge, the data concerning the association
between sleep disorders and Hashimoto disease is the first
such evidence published in literature, although it may be
consistent with a dysregulation of sleep architecture in
subjects with sub-clinical thyroid impairment [12].
A sub-clinical dysfunction of axis thyrotropin releasing
hormone (TRH) thyroid stimulating hormone (TSH) with
consequent alteration of circadian rhythms of TSH has
been hypothesized in several depressive disorders.
Indeed, this hypothesis may explain why some forms of
mood disorders were associated with anti-TPO+ without
hypothyroidism, as defined by blood routine tests. A
slight reduction in thyroid hormone secretion such as that
found in sub-clinical hypothyroidism may affect cogni-
tion and mood [13]. At variance with other tissues which
mainly rely on peripherally generated triiodothyronine,
the brain utilizes preferentially circulating thyroxine
directly secreted by the thyroid gland and may become
hypothyroid before other organs [10].
Alternatively, autoimmunity may be implicated in some
form of extra-thyroid disease associated (even indirectly)
with the depressive symptomatology.
In Hashimoto disease the onset of vasculitis is frequently
observed and would seem to be directly correlated to the
duration of the illness [14].
In this disease brain perfusion modifications would
appear to be of an aspecific nature; recently however,
Spect examination revealed a marked compromising of
the left cingulum posterioris, thus related in the etiology
of associated affective disorders [14].
Recent evidence suggests that thyroid autoimmunity may
be affected by the Hypothalamic-pituitary-adrenal axis
(HPA) through the balance of proinflammatory and anti-
inflammatory cytokines [15,16]. In line with this view, the
increased frequency of post-partum depression, associ-
ated to the fact that pregnancy would seem to be a "pro-
tected" period, could explain at least in part the
consequences on thyroid autoimmunity elicited by HPA-
related modifications to the immunitary axis. Indeed,
similar phenomena are observed in both rheumatoid
arthritis and multiple sclerosis and therefore Hashimoto
vasculitis may also be involved [17].
Limitations
The potential of this study is limited by the small sample
size, particularly regard to psychiatric diagnoses less fre-
quently observed in the general population, such as Panic
Disorder; the extension of the findings is therefore rather
limited.
Conclusion
This study seems to indicate an association between the
presence of a lifetime diagnosis of mood or anxiety disor-
der and sleep disturbance and anti-TPO+. The findings
obtained suggest the need for further longitudinal studies
aimed at clarifying the association between anxiety and
depressive disorders and anti-TPO+.
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